These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 10733600

  • 1. New quinoxalinecarbonitrile 1,4-di-N-oxide derivatives as hypoxic-cytotoxic agents.
    Ortega MA, Morancho MJ, Martínez-Crespo FJ, Sainz Y, Montoya ME, López de Ceráin A, Monge A.
    Eur J Med Chem; 2000 Jan; 35(1):21-30. PubMed ID: 10733600
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia-selective agents derived from 2-quinoxalinecarbonitrile 1,4-di-N-oxides. 2.
    Monge A, Martínez-Crespo FJ, López de Ceráin A, Palop JA, Narro S, Senador V, Marín A, Sainz Y, González M, Hamilton E.
    J Med Chem; 1995 Oct 27; 38(22):4488-94. PubMed ID: 7473576
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia-selective agents derived from quinoxaline 1,4-di-N-oxides.
    Monge A, Palop JA, López de Ceráin A, Senador V, Martínez-Crespo FJ, Sainz Y, Narro S, García E, de Miguel C, González M.
    J Med Chem; 1995 May 12; 38(10):1786-92. PubMed ID: 7752202
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and biological evaluation of new 2-arylcarbonyl-3-trifluoromethylquinoxaline 1,4-di-N-oxide derivatives and their reduced analogues.
    Solano B, Junnotula V, Marín A, Villar R, Burguete A, Vicente E, Pérez-Silanes S, Aldana I, Monge A, Dutta S, Sarkar U, Gates KS.
    J Med Chem; 2007 Nov 01; 50(22):5485-92. PubMed ID: 17910426
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as hypoxia-selective cytotoxins.
    Monge A, López de Ceráin A, Ezpeleta O, Cerecetto H, Dias E, Di Maio R, González M, Onetto S, Seoane G, Suescun L, Mariezcurrena R.
    Pharmazie; 1998 Nov 01; 53(11):758-64. PubMed ID: 9853357
    [Abstract] [Full Text] [Related]

  • 6. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part II.
    Cerecetto H, González M, Onetto S, Saenz P, Ezpeleta O, De Ceráin AL, Monge A.
    Arch Pharm (Weinheim); 2004 May 01; 337(5):247-58. PubMed ID: 15095418
    [Abstract] [Full Text] [Related]

  • 7. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
    Amin KM, Ismail MM, Noaman E, Soliman DH, Ammar YA.
    Bioorg Med Chem; 2006 Oct 15; 14(20):6917-23. PubMed ID: 16843668
    [Abstract] [Full Text] [Related]

  • 8. New quinoxaline 1,4-di-N-oxides for treatment of tuberculosis.
    Sainz Y, Montoya ME, Martínez-Crespo FJ, Ortega MA, López de Ceráin A, Monge A.
    Arzneimittelforschung; 1999 Jan 15; 49(1):55-9. PubMed ID: 10028381
    [Abstract] [Full Text] [Related]

  • 9. Ester of Quinoxaline-7-carboxylate 1,4-di-N-oxide as Apoptosis Inductors in K-562 Cell Line: An in vitro, QSAR and DFT Study.
    Rivera G, Andrade-Ochoa S, Romero MSO, Palos I, Monge A, Sanchez-Torres LE.
    Anticancer Agents Med Chem; 2017 Jan 15; 17(5):682-691. PubMed ID: 27396382
    [Abstract] [Full Text] [Related]

  • 10. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part III.
    Cerecetto H, González M, Risso M, Saenz P, Olea-Azar C, Bruno AM, Azqueta A, De Ceráin AL, Monge A.
    Arch Pharm (Weinheim); 2004 May 15; 337(5):271-80. PubMed ID: 15095420
    [Abstract] [Full Text] [Related]

  • 11. Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs: Part 1. 8-Alkylamino-substituted phenylimidazo [1,2-a] quinoxalines.
    Naylor MA, Stephens MA, Nolan J, Sutton B, Tocher JH, Fielden EM, Adams GE, Stratford IJ.
    Anticancer Drug Des; 1993 Dec 15; 8(6):439-61. PubMed ID: 8286012
    [Abstract] [Full Text] [Related]

  • 12. Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine.
    Mallams AK, Rossman RR, Doll RJ, Girijavallabhan VM, Ganguly AK, Petrin J, Wang L, Patton R, Bishop WR, Carr DM, Kirschmeier P, Catino JJ, Bryant MS, Chen KJ, Korfmacher WA, Nardo C, Wang S, Nomeir AA, Lin CC, Li Z, Chen J, Lee S, Dell J, Lipari P, Liu M.
    J Med Chem; 1998 Mar 12; 41(6):877-93. PubMed ID: 9526562
    [Abstract] [Full Text] [Related]

  • 13. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
    Jaso A, Zarranz B, Aldana I, Monge A.
    J Med Chem; 2005 Mar 24; 48(6):2019-25. PubMed ID: 15771444
    [Abstract] [Full Text] [Related]

  • 14. Synthesis and in vitro evaluation of new ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide against Entamoeba histolytica.
    Duque-Montaño BE, Gómez-Caro LC, Sanchez-Sanchez M, Monge A, Hernández-Baltazar E, Rivera G, Torres-Angeles O.
    Bioorg Med Chem; 2013 Aug 01; 21(15):4550-8. PubMed ID: 23787289
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and antiplasmodial activity of 3-furyl and 3-thienylquinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.
    Vicente E, Charnaud S, Bongard E, Villar R, Burguete A, Solano B, Ancizu S, Pérez-Silanes S, Aldana I, Vivas L, Monge A.
    Molecules; 2008 Jan 17; 13(1):69-77. PubMed ID: 18259130
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents.
    Urquiola C, Gambino D, Cabrera M, Lavaggi ML, Cerecetto H, González M, de Cerain AL, Monge A, Costa-Filho AJ, Torre MH.
    J Inorg Biochem; 2008 Jan 17; 102(1):119-26. PubMed ID: 17804074
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and biological evaluation of 3-aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives as hypoxic selective anti-tumor agents.
    Hu Y, Xia Q, Shangguan S, Liu X, Hu Y, Sheng R.
    Molecules; 2012 Aug 13; 17(8):9683-96. PubMed ID: 22890172
    [Abstract] [Full Text] [Related]

  • 20. Quinoxaline 1,4-dioxides as anticancer and hypoxia-selective drugs.
    Gali-Muhtasib HU, Haddadin MJ, Rahhal DN, Younes IH.
    Oncol Rep; 2001 Aug 13; 8(3):679-84. PubMed ID: 11295102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.